Cargando...
Intestinal barrier dysfunction as a therapeutic target for cardiovascular disease
The gut microbiome and intestinal dysfunction have emerged as potential contributors to the development of cardiovascular disease (CVD). Alterations in gut microbiome are well documented in hypertension, atherosclerosis, and heart failure and have been investigated as a therapeutic target. However,...
Gardado en:
| Publicado en: | Am J Physiol Heart Circ Physiol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Physiological Society
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7792706/ https://ncbi.nlm.nih.gov/pubmed/32986965 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpheart.00612.2020 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|